Global Remdesivir (COVID-19) Market Research Report 2021

1 Remdesivir (COVID-19) Market Overview

• 1.1 Product Overview and Scope of Remdesivir (COVID-19)
• 1.2 Remdesivir (COVID-19) Segment by Type
  • 1.2.1 Global Remdesivir (COVID-19) Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 5mg
  • 1.2.3 10mg
  • 1.2.4 50mg
  • 1.2.5 100mg
• 1.3 Remdesivir (COVID-19) Segment by Application
  • 1.3.1 Remdesivir (COVID-19) Sales Comparison by Application: (2021-2027)
  • 1.3.2 Hospital
  • 1.3.3 Clinics
  • 1.3.4 Drug Store
  • 1.3.5 Others
• 1.4 Global Remdesivir (COVID-19) Market Size Estimates and Forecasts
  • 1.4.1 Global Remdesivir (COVID-19) Revenue 2016-2027
  • 1.4.2 Global Remdesivir (COVID-19) Sales 2016-2027
  • 1.4.3 Remdesivir (COVID-19) Market Size by Region: 2016 Versus 2021 Versus 2027

2 Remdesivir (COVID-19) Market Competition by Manufacturers

• 2.1 Global Remdesivir (COVID-19) Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Remdesivir (COVID-19) Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Remdesivir (COVID-19) Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Remdesivir (COVID-19) Manufacturing Sites, Area Served, Product Type
• 2.5 Remdesivir (COVID-19) Market Competitive Situation and Trends
  • 2.5.1 Remdesivir (COVID-19) Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Remdesivir (COVID-19) Players Market Share by Revenue
  • 2.5.3 Global Remdesivir (COVID-19) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Remdesivir (COVID-19) Retrospective Market Scenario by Region

• 3.1 Global Remdesivir (COVID-19) Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Remdesivir (COVID-19) Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Remdesivir (COVID-19) Market Facts & Figures by Country
  • 3.3.1 North America Remdesivir (COVID-19) Sales by Country
  • 3.3.2 North America Remdesivir (COVID-19) Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Remdesivir (COVID-19) Market Facts & Figures by Country
  • 3.4.1 Europe Remdesivir (COVID-19) Sales by Country
  • 3.4.2 Europe Remdesivir (COVID-19) Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Remdesivir (COVID-19) Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Remdesivir (COVID-19) Sales by Region
  • 3.5.2 Asia Pacific Remdesivir (COVID-19) Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Remdesivir (COVID-19) Market Facts & Figures by Country
  • 3.6.1 Latin America Remdesivir (COVID-19) Sales by Country
  • 3.6.2 Latin America Remdesivir (COVID-19) Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Remdesivir (COVID-19) Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Remdesivir (COVID-19) Sales by Country
  • 3.7.2 Middle East and Africa Remdesivir (COVID-19) Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Remdesivir (COVID-19) Historic Market Analysis by Type

• 4.1 Global Remdesivir (COVID-19) Sales Market Share by Type (2016-2021)
• 4.2 Global Remdesivir (COVID-19) Revenue Market Share by Type (2016-2021)
• 4.3 Global Remdesivir (COVID-19) Price by Type (2016-2021)

5 Global Remdesivir (COVID-19) Historic Market Analysis by Application

• 5.1 Global Remdesivir (COVID-19) Sales Market Share by Application (2016-2021)
• 5.2 Global Remdesivir (COVID-19) Revenue Market Share by Application (2016-2021)
• 5.3 Global Remdesivir (COVID-19) Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Gilead Sciences
  • 6.1.1 Gilead Sciences Corporation Information
  • 6.1.2 Gilead Sciences Description and Business Overview
  • 6.1.3 Gilead Sciences Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Gilead Sciences Product Portfolio
  • 6.1.5 Gilead Sciences Recent Developments/Updates
• 6.2 Bright Gene
  • 6.2.1 Bright Gene Corporation Information
  • 6.2.2 Bright Gene Description and Business Overview
  • 6.2.3 Bright Gene Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Bright Gene Product Portfolio
  • 6.2.5 Bright Gene Recent Developments/Updates
• 6.3 Hainan Haiyao
  • 6.3.1 Hainan Haiyao Corporation Information
  • 6.3.2 Hainan Haiyao Description and Business Overview
  • 6.3.3 Hainan Haiyao Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Hainan Haiyao Product Portfolio
  • 6.3.5 Hainan Haiyao Recent Developments/Updates
• 6.4 Kelun Pharma
  • 6.4.1 Kelun Pharma Corporation Information
  • 6.4.2 Kelun Pharma Description and Business Overview
  • 6.4.3 Kelun Pharma Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Kelun Pharma Product Portfolio
  • 6.4.5 Kelun Pharma Recent Developments/Updates
• 6.5 Hunan Warrant Pharmaceutical
  • 6.5.1 Hunan Warrant Pharmaceutical Corporation Information
  • 6.5.2 Hunan Warrant Pharmaceutical Description and Business Overview
  • 6.5.3 Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Hunan Warrant Pharmaceutical Product Portfolio
  • 6.5.5 Hunan Warrant Pharmaceutical Recent Developments/Updates
• 6.6 Borui Bio-Pharmaceutical
  • 6.6.1 Borui Bio-Pharmaceutical Corporation Information
  • 6.6.2 Borui Bio-Pharmaceutical Description and Business Overview
  • 6.6.3 Borui Bio-Pharmaceutical Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Borui Bio-Pharmaceutical Product Portfolio
  • 6.6.5 Borui Bio-Pharmaceutical Recent Developments/Updates
• 6.7 Berry Global Group
  • 6.6.1 Berry Global Group Corporation Information
  • 6.6.2 Berry Global Group Description and Business Overview
  • 6.6.3 Berry Global Group Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Berry Global Group Product Portfolio
  • 6.7.5 Berry Global Group Recent Developments/Updates
• 6.8 Inovio Pharmaceuticals
  • 6.8.1 Inovio Pharmaceuticals Corporation Information
  • 6.8.2 Inovio Pharmaceuticals Description and Business Overview
  • 6.8.3 Inovio Pharmaceuticals Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Inovio Pharmaceuticals Product Portfolio
  • 6.8.5 Inovio Pharmaceuticals Recent Developments/Updates

7 Remdesivir (COVID-19) Manufacturing Cost Analysis

• 7.1 Remdesivir (COVID-19) Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Remdesivir (COVID-19)
• 7.4 Remdesivir (COVID-19) Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Remdesivir (COVID-19) Distributors List
• 8.3 Remdesivir (COVID-19) Customers

9 Remdesivir (COVID-19) Market Dynamics

• 9.1 Remdesivir (COVID-19) Industry Trends
• 9.2 Remdesivir (COVID-19) Growth Drivers
• 9.3 Remdesivir (COVID-19) Market Challenges
• 9.4 Remdesivir (COVID-19) Market Restraints

10 Global Market Forecast

• 10.1 Remdesivir (COVID-19) Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Remdesivir (COVID-19) by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Remdesivir (COVID-19) by Type (2022-2027)
• 10.2 Remdesivir (COVID-19) Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Remdesivir (COVID-19) by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Remdesivir (COVID-19) by Application (2022-2027)
• 10.3 Remdesivir (COVID-19) Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Remdesivir (COVID-19) by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Remdesivir (COVID-19) by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List